🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142
Thalidomide-Dexamethasone (TD) is a standard induction therapy for Multiple...
Status
Unknown
Location
AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia
Start Date
2006-05
Trial ID
NCT01134484
RATIONALE: Sometimes the cancer may not need treatment until it progresses....
Status
Withdrawn
Location
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Start Date
2008-09
Trial ID
NCT00723658
Comparison of the efficacy and safety of microtransplantation and autologou...
Status
Unknown
Location
Beijing Chaoyang Hospital
Start Date
2016-01
Trial ID
NCT02981199
Treatments Being Tested
This study will assess whether adding one of the newest multiple myeloma th...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2017-07-01
Trial ID
NCT03004287
In this study, researchers want to find out if using the VTD regimen, along...
Status
Withdrawn
Location
University of Arkansas for Medical Sciences
Start Date
2007-04
Trial ID
NCT00577668
Treatments Being Tested
This is a multicenter, open-label phase II study, assessing the efficacy of...
Status
Withdrawn
Location
Hématologie et thérapie cellulaire, Hôpital Saint Antoine
Start Date
2018-02-20
Trial ID
NCT03393273
Treatments Being Tested
This phase II trial investigates whether patients greater than or equal to ...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2013-04-04
Trial ID
NCT01849783
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Withdrawn
Location
Tulane Cancer Center Office of Clinical Research
Start Date
2011-07
Trial ID
NCT01055301